ICW Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,600
Closed -$3.51M 147
2025
Q3
$3.51M Buy
+4,600
New +$3.42M 1.26% 24

Other funds holding LLY

ICW Investment Advisors's LLY Position: Q1 2026 in Review

ICW Investment Advisors reduced its Eli Lilly (LLY) stake by 41% in Q1 2026, selling an estimated $2.34M and leaving 3,339 shares worth $3.07M. The position accounts for 1.11% of the portfolio, ranked #30.

ICW Investment Advisors first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $6.07M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • ICW Investment Advisors held 3,339 shares of Eli Lilly worth $3.07M as of Q1 2026.
  • ICW Investment Advisors sold 2,313 Eli Lilly shares in Q1 2026, an estimated $2.34M.
  • Eli Lilly made up 1.11% of ICW Investment Advisors's portfolio in Q1 2026, its #30 holding.
  • ICW Investment Advisors first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • ICW Investment Advisors's Eli Lilly position peaked at $6.07M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on ICW Investment Advisors's 13F filing for Q1 2026, filed 11 May 2026.